🔬 Dr. Bo Meng is an Associate Director at WuXi Biologics, Shanghai 🇨🇳 (2017–present), leading 30+ CMC projects for biologics like antibodies, enzymes, and vaccines. 💉 He manages a team of 20+ scientists, driving innovations from pre-IND to BLA filings. Previously, he was a Research Scientist at Omicron Biochemicals, USA 🇺🇸, focusing on glycan synthesis. 🧪 Dr. Meng earned his Ph.D. in Organic Chemistry from the University of Tennessee 🎓 and a B.Sc. in Applied Chemistry from Beijing Institute of Technology. 📖 His research is published in top journals, and he holds a Lean Six Sigma Green Belt. 🏆
Publication Profile
Orcid
Education
Dr. Bo Meng 🎓 earned a Ph.D. in Organic Chemistry 🧪 from the University of Tennessee, Knoxville 🇺🇸, completing his studies in August 2015. His academic journey began at Beijing Institute of Technology 🇨🇳, where he obtained a Bachelor’s degree in Applied Chemistry ⚗️ in June 2010. With a strong foundation in chemical sciences and research, Dr. Meng has developed expertise in organic synthesis and chemical applications. His educational background reflects a dedication to advancing scientific knowledge and contributing to innovative research in the field of chemistry 🔍🔬.
Working Experience
Dr. Bo Meng is the Associate Director at WuXi Biologics in Shanghai, China (2017–present) 🇨🇳🔬. With expertise in biologics development, he leads 30+ CMC projects, including antibodies, fusion proteins, ADCs, enzymes, vaccines, and mRNA 💉🧬. As Project Head, he oversees cell line development, process optimization, and regulatory filings from pre-IND to BLA 📑⚙️. He also manages a 20-person analytical team, ensuring robust assay development, product stability, and regulatory compliance. Previously, he worked at Omicron Biochemicals Inc. in the USA (2015–2017) 🇺🇸⚗️, contributing significantly to innovative biopharmaceutical advancements.
Research Scientist
Dr. Bo Meng specializes in the chemical and enzymatic synthesis, purification, and analysis of oligosaccharides 🧪, with a focus on high-mannose N-glycans, mannose phosphates, and 13C-labeled sugars 🧬. These complex carbohydrates play a crucial role as therapeutic targets in pathology and immunological studies 🩺🛡️. Through innovative research and advanced analytical techniques, Dr. Meng contributes to the development of new treatments and diagnostic tools for various diseases. Their work bridges the gap between biochemical research and medical applications, enhancing our understanding of immune responses and disease mechanisms for better healthcare solutions 🌱💡.
Research Focus
Dr. Bo Meng’s research spans biopharmaceuticals, carbohydrate chemistry, and materials science. 🧪🔬 His recent work investigates excipient impacts on polysorbate 80 degradation in biopharmaceutical formulations. 💉🧫 He has explored regioselective glycosylation to synthesize high-mannose oligosaccharides with mannose-6-phosphate residues. 🍬⚛️ Additionally, Dr. Meng has contributed to developing hyper-crosslinked cyclodextrin polymers for efficient CO₂ capture and catalytic applications. 🌿🛠️ His innovative work in carbohydrate-based materials showcases potential for green chemistry, biotechnology, and drug formulation. 🌏💊 Through interdisciplinary approaches, he advances solutions for environmental challenges and pharmaceutical stability. 📈🔍
Publication Top Notes